Federated Hermes
VIR icon

Federated Hermes’s Vir Biotechnology VIR Stock Holding History

Federated Hermes’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,739
Closed -$42.5K – 2190
2026
Q1 		$42.5K Buy
4,739
+734
+18% +$5.85K ﹤0.01% 1696
2025
Q4 		$24.1K Sell
4,005
-4,080
-50% -$24.3K ﹤0.01% 1733
2025
Q3 		$46.2K Buy
8,085
+4,899
+154% +$25.1K ﹤0.01% 1684
2025
Q2 		$16.1K Sell
3,186
-15
-0.5% -$80 ﹤0.01% 1744
2025
Q1 		$20.7K Sell
3,201
-3,420
-52% -$30.4K ﹤0.01% 1719
2024
Q4 		$48.6K Sell
6,621
-44,630
-87% -$352K ﹤0.01% 1674
2024
Q3 		$384K Sell
51,251
-248,897
-83% -$2.16M ﹤0.01% 1377
2024
Q2 		$2.67M Buy
300,148
+298,603
+19,327% +$2.86M 0.01% 857
2024
Q1 		$15.7K Sell
1,545
-5,313
-77% -$54.1K ﹤0.01% 1746
2023
Q4 		$69K Buy
+6,858
New +$62.7K ﹤0.01% 1614
2023
Q3 		– Sell
-1,140
Closed -$28K – 2209
2023
Q2 		$28K Sell
1,140
-946
-45% -$23.8K ﹤0.01% 1749
2023
Q1 		$48.5K Buy
2,086
+286
+16% +$7.32K ﹤0.01% 1738
2022
Q4 		$45.6K Sell
1,800
-236,113
-99% -$5.79M ﹤0.01% 1726
2022
Q3 		$4.59M Buy
+237,913
New +$6.05M 0.01% 692
2022
Q2 		– Sell
-74
Closed -$2K – 2288
2022
Q1 		$2K Buy
+74
New +$2.19K ﹤0.01% 2039
2020
Q2 		– Sell
-26,058
Closed -$893K – 2382
2020
Q1 		$893K Buy
+26,058
New +$700K ﹤0.01% 1182

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Federated Hermes's VIR Position: Q2 2026 in Review

Federated Hermes sold out of Vir Biotechnology (VIR) in Q2 2026, closing a stake of 4,739 shares — an estimated $42.5K sold.

Federated Hermes first reported a position in VIR in Q1 2020 and held it in 16 quarters. The position peaked at $4.59M in Q3 2022. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Federated Hermes reported no remaining Vir Biotechnology position as of Q2 2026 after selling out during the quarter.
  • Federated Hermes sold 4,739 Vir Biotechnology shares in Q2 2026, an estimated $42.5K.
  • Federated Hermes first reported a position in Vir Biotechnology in Q1 2020 and held it in 16 quarters.
  • Federated Hermes's Vir Biotechnology position peaked at $4.59M in Q3 2022.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.